BOSTON--(BUSINESS WIRE)--Cortria Corporation today announced the appointment of Dennis H. Giesing, Ph.D., as Head of Research and Development. Dr. Giesing brings over thirty years of experience in pharmaceutical drug development, most recently at Aventis Pharmaceuticals where he had worldwide responsibility for the Aventis R&D product pipeline from late discovery through early clinical development.
